Standard Biotools (LAB) EBIT Margin (2010 - 2026)
Standard Biotools' (LAB) quarterly EBIT Margin came in at 59.09% in Q1 2026, up 7428.0% year-on-year from 0.78% in Q1 2025, and up 42.94% on a QoQ basis from 103.57% in Q4 2025.
Standard Biotools (LAB) EBIT Margin (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has 17 years of EBIT Margin data on file, last reported at 59.09% in Q1 2026.
- On a quarterly basis, EBIT Margin rose 7428.0% year-over-year to 59.09% in Q1 2026; TTM through Mar 2026 was 111.04%, a 1178.0% increase from a year earlier, with the FY2025 full-year figure at 129.2%, up 1088.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 59.09%, up from 103.57% in the prior quarter.
- Over the last five years, EBIT Margin for LAB reached as high as 59.09% in Q1 2026 and fell as low as 205.37% in Q2 2022.
- Historically, EBIT Margin has averaged 109.67% across 5 years, with a median of 105.27% in 2024.
- Across the five-year window, EBIT Margin plunged 14804 bps in 2022 and surged 14230 bps in 2023, its largest moves.
- Year by year, EBIT Margin stood at 78.13% in 2022, then grew by 3 bps to 75.87% in 2023, then plunged by 39 bps to 105.27% in 2024, then increased by 2 bps to 103.57% in 2025, then surged by 43 bps to 59.09% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 59.09% in Q1 2026, 103.57% in Q4 2025, and 168.46% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 6.17% |
| 10 | Standard Biotools | 315.49 Mn | -139.68 Mn | 11.31 Mn | -59.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.09% |
| Dec 31, 2025 | -103.57% |
| Sep 30, 2025 | -168.46% |
| Jun 30, 2025 | -118.08% |
| Mar 31, 2025 | -133.37% |
| Dec 31, 2024 | -105.27% |
| Sep 30, 2024 | -120.89% |
| Jun 30, 2024 | -134.54% |
| Mar 31, 2024 | -132.15% |
| Dec 31, 2023 | -75.87% |
| Sep 30, 2023 | -83.46% |
| Jun 30, 2023 | -63.07% |
| Mar 31, 2023 | -66.06% |
| Dec 31, 2022 | -78.13% |
| Sep 30, 2022 | -113.18% |
| Jun 30, 2022 | -205.37% |
| Mar 31, 2022 | -103.77% |
| Sep 30, 2021 | -60.88% |
| Jun 30, 2021 | -57.34% |
| Mar 31, 2021 | -58.91% |